Trial Results Summaries
Respect patients as partners by providing plain language trial results summaries.
Utilize our highly specialized, award-winning program to develop and share aggregate trial results summaries with study participants and the general public.
The Problem
Most trial participants feel they are “no longer valued” by researchers at the conclusion of their trial.1
According to CISCRP’s 2019 Perceptions & Insights Study, both participants of clinical trials and those who have never participated agree that access to supporting information about clinical trials is a top priority.2
Per the CISCRP survey, 85% of respondents who had participated in a clinical trial reported that it is “somewhat important” or “very important” to receive a summary of the results of the clinical trial. However, the majority (61%) reported that they did not receive any reports or updates on the results of their trial once they completed their participation. 39% reported they never even heard back from anyone after the trial was over.
61%
of participants did not receive any reports on the results of their trial
CISCRP's Solution
Prior to reviewing one of our lay language summaries, only 11% of participants understood basic facts about the trial (such as why the research had been conducted).3 After independently reviewing one of our lay language summaries, 91% of trial participants felt they understood the trial result communications “very well” or “somewhat well.”
We collaborate and consult extensively with research sponsors to ensure their results communications are understandable, meet applicable regulatory requirements, and follow current and emerging industry best practices.
Trial results summaries include all required elements for layperson summaries identified in Annex V of the 2014 EU Clinical Trials Regulation, which is necessary for a summary to be published in the EU database.
Program Setup
Consult with us to set up your trial results summary program.
- Apply more than a decade’s worth of our experience to standardize a global program to develop and share aggregate trial results summaries
- Operationalize our insights from hundreds of projects with sponsors across all therapeutic areas, phases, and study types
- Utilize our knowledge to develop all the necessary templates, operating procedures, guidelines, training, and tools
- Getz. The Monitor. September 2008: 17-21.
- 2019 CISCRP P&I Study, n=12,451
- Getz et al. 2012. Expert Rev. Clin. Pharmacol. 5(2): 149-156
- Informa Connect, Clinical Trials Europe Conference Award, 2014.
English
Spanish
Portuguese
Chinese (Simplified)
Arabic
Dutch
French
German
Italian
Russian
